GOSS
Gossamer Bio Inc
10.90$
+0.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 14.8% | – | 1.0% | – | 11.5% | – | – | – | 1.6% | 1.4% | – | – | |
| – | 85.2% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 98.6% | 100.0% | 99.6% | |
| – | 441.8% | – | 36.6% | 368.1% | 385.0% | 384.7% | 361.9% | 398.8% | 354.6% | 254.0% | 285.9% | 321.7% | |
| – | 133.5% | – | 9.0% | 89.7% | 100.2% | 87.6% | 75.5% | 70.6% | 79.0% | 110.6% | 96.3% | 90.0% | |
| – | 722.7% | – | 45.7% | 457.8% | 485.2% | 472.2% | 437.4% | 469.4% | 433.6% | 363.2% | 382.2% | 411.3% | |
| – | -722.7% | – | 54.3% | -357.8% | -385.2% | -372.2% | -337.4% | -369.4% | -333.6% | -264.6% | -282.2% | -311.7% | |
| – | 47.7% | – | 3.0% | 28.8% | 29.2% | 27.8% | 23.9% | 20.7% | 19.9% | 16.2% | 29.3% | 20.6% | |
| – | -709.7% | – | 56.0% | -336.9% | -377.9% | -370.5% | -333.1% | -362.7% | -343.0% | -275.2% | 182.9% | -235.2% | |
| – | -316.2% | – | 4.6% | -11.9% | -25.7% | – | – | – | -0.6% | – | – | – | |
| – | -709.7% | – | 51.4% | -324.9% | -352.2% | -370.5% | -333.1% | -362.7% | -342.3% | -275.2% | 182.9% | -235.0% | |
| – | -647.2% | – | 60.1% | -296.4% | -337.2% | -339.3% | -307.4% | -342.0% | -321.4% | -257.6% | -773.8% | -384.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.